Tag Archives: boosts

Novo Nordisk boosts its GLP-1 score with yet more evidence for crucial semaglutide pill

Novo Nordisk rolled out its latest set of data for its next great hope: the oral version of semaglutide, which would become the only pill in the increasingly competitive GLP-1 class. In trial No. 8 of a 10-trial program, which tested oral semaglutide in longtime diabetes patients, the drug beat placebo at reducing blood sugar… Read More »